Evidence map›Paper›PMID 17715392›Full record

ArticleBlood2007

Novel role for EKLF in megakaryocyte lineage commitment.

Pilar Frontelo, Deepa Manwani, Mariann Galdass, Holger Karsunky, Felix Lohmann, Patrick G Gallagher, James J Bieker

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 135 citations in OpenAlex.

  1. Article
  2. Article
  3. Heterozygous nonsenseResearch and practice in thrombosis and haemostasis · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Pilar FronteloMount Sinai School of Medicine, New York, NY 10029, USA.
Deepa Manwani
Mariann Galdass
Holger Karsunky
Felix Lohmann
Patrick G Gallagher
James J Bieker
Icahn School of Medicine at Mount Sinai · USStanford University · USYale University · US

Funding

Function of Putative Determinant in HematopoiesisR01DK046865 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI JAMES J BIEKER · 1993 to 2026
$11.2M
MOLECULAR BIOLOGY OF HUMAN ERYTHROCYTE ALPHA-SPECTRINR01HL065448 · NHLBI · YALE UNIVERSITY · PI GALLAGHER, PATRICK G · 2000 to 2013
$4.4M
HEMATOPOIETIC STEM CELL COMMITMENT--MOLECULAR REGULATIONR01DK048721 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI BIEKER, JAMES J · 1996 to 2004
$1.0M
USE OF MODIFIED EKLF FOR GAMMA GLOBIN AUGMENTATIONK08DK002871 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI MANWANI, DEEPA G · 2000 to 2004
$631k
NHLBI NIH HHS R01 HL065448NHLBI NIH HHS R01 HL65448NIDDK NIH HHS DK48721NIDDK NIH HHS K08 DK002871NIDDK NIH HHS K08 DK02871NIDDK NIH HHS R01 DK046865NIDDK NIH HHS R01 DK048721NIDDK NIH HHS R01 DK46865
6 · The paper itself

Abstract

Megakaryocytes and erythroid cells are thought to derive from a common progenitor during hematopoietic differentiation. Although a number of transcriptional regulators are important for this process, they do not explain the bipotential result. We now show by gain- and loss-of-function studies that erythroid Krüppel-like factor (EKLF), a transcription factor whose role in erythroid gene regulation is well established, plays an unexpected directive role in the megakaryocyte lineage. EKLF inhibits the formation of megakaryocytes while at the same time stimulating erythroid differentiation. Quantitative examination of expression during hematopoiesis shows that, unlike genes whose presence is required for establishment of both lineages, EKLF is uniquely down-regulated in megakaryocytes after formation of the megakaryocyte-erythroid progenitor. Expression profiling and molecular analyses support these observations and suggest that megakaryocytic inhibition is achieved, at least in part, by EKLF repression of Fli-1 message levels.

Indexed as

AnimalsCell DifferentiationCell LineEmbryonic Stem CellsGene Expression ProfilingGene Expression RegulationHematopoiesisHumansKruppel-Like Transcription FactorsMegakaryocytesProto-Oncogene Protein c-fli-1RNA, Messengererythroid Kruppel-like factorKruppel-Like Transcription FactorsProto-Oncogene Protein c-fli-1RNA, Messenger

Identifiers

PMID17715392
PMCPMC2190608
OpenAlexW2150729435

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.